Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Neutrophil gelatinase-associated lipocalin"

Article category

Keywords

Publication year

"Neutrophil gelatinase-associated lipocalin"

Review

Liver fibrosis, cirrhosis, and portal hypertension

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol 2022;28(1):31-46.
Published online August 2, 2021
DOI: https://doi.org/10.3350/cmh.2021.0148
Acute kidney injury (AKI) is common in advanced cirrhosis. Prerenal azotemia, hepatorenal syndrome, and acute tubular necrosis are the main causes of AKI in patients with cirrhosis. Evaluation of renal function and differentiation between functional and structural kidney injury are important issues in the management of cirrhosis. However, AKI in cirrhosis exists as a complex clinical spectrum rather than concrete clinical entity. Based on current evidence, changes in serum creatinine (Cr) levels remain the most appropriate standard for defining AKI in cirrhosis. However, serum Cr has a limited role in assessing renal function in this population. This review examines previous studies that investigated the ability of recent biomarkers for AKI in cirrhosis from the perspective of earlier and accurate diagnosis, classification of AKI phenotype, and prediction of clinical outcomes. Serum cystatin C and urine neutrophil gelatinase-associated lipocalin have been extensively studied in cirrhosis, and have facilitated improved diagnosis and prognosis prediction in patients with AKI. In addition, urine N-acetyl-β-D-glucosaminidase, interleukin 18, and kidney injury molecule 1 are other promising biomarkers for advanced cirrhosis. However, the clinical significance of these markers remains unclear because there are no cut-off values defining the normal range and differentiating phenotypes of AKI. In addition, AKI has been defined in terms of serum Cr, and renal biopsy—the gold standard—has not been carried out in most studies. Further discovery of innovate biomarkers and incorporation of various markers could improve the diagnosis and prognosis prediction of AKI, and will translate into meaningful improvements in patient outcomes.

Citations

Citations to this article as recorded by  Crossref logo
  • Evaluation of Acute Kidney Injury (AKI) Biomarkers FABP1, NGAL, Cystatin C and IL-18 in an Indian Cohort of Hospitalized Acute-on-chronic Liver Failure (ACLF) Patients
    Rohini Saha, Samriddhi Sharma, Antara Mondal, Hem C. Sati, Maroof A. Khan, Sandeep Mahajan, Sudip Datta, Shalimar, Pragyan Acharya
    Journal of Clinical and Experimental Hepatology.2025; 15(3): 102491.     CrossRef
  • The efficacy of novel biomarkers for the early detection and management of acute kidney injury: A systematic review
    Mohammed Yousef Almulhim, Gianpaolo Reboldi
    PLOS ONE.2025; 20(1): e0311755.     CrossRef
  • Neutrophil gelatinase–associated lipocalin for predicting acute kidney injury in orthotopic liver transplantation: a systematic review and meta-analysis
    Fangran Yan, Zenghua Zhou, Xueke Du, Sheng He, Linghui Pan
    European Journal of Gastroenterology & Hepatology.2025; 37(6): 683.     CrossRef
  • Understanding acute kidney injury in cirrhosis: Current perspective
    Sayan Malakar, Sumit Rungta, Arghya Samanta, Umair Shamsul Hoda, Piyush Mishra, Gaurav Pande, Akash Roy, Suprabhat Giri, Praveer Rai, Samir Mohindra, Uday C Ghoshal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Protective effects of Katsuwonus pelamis hydrolysates against renal injury: Val-Lys as a potent renoprotective peptide
    Ying Cheng, Mingjie Zhou, Zishan Hong, Lin Zheng, Mouming Zhao
    Food & Function.2025; 16(13): 5616.     CrossRef
  • Acute Kidney Injury in Patients with Liver Cirrhosis: From Past to Present Definition and Diagnosis
    Andreea Lungu, Georgiana-Elena Sarbu, Alexandru Sebastian Cotlet, Ilie-Andreas Savin, Ioana-Roxana Damian, Simona Juncu, Cristina Muzica, Irina Girleanu, Ana-Maria Sîngeap, Carol Stanciu, Anca Trifan, Camelia Cojocariu
    Life.2025; 15(8): 1249.     CrossRef
  • The Value of Diffusion Kurtosis Imaging to Assess Liver and Kidney Recovery after Mesenchymal Stem Cell Intervention in CCl4-Induced Cirrhotic Rats
    Jiaming Qin, Shuangshuang Xie, Yongquan Yu, Cheng Zhang, Yumeng Zhao, Dan Tong, Zhandong Hu, Jinxia Zhu, Wen Shen
    American Journal of Nephrology.2025; 56(4): 475.     CrossRef
  • CIRROSE HEPÁTICA EM ESTÁGIO AVANÇADO E O PAPEL DO TRANSPLANTE DE FÍGADO: DESAFIOS ATUAIS E PERSPECTIVAS FUTURAS NO MANEJO DE PACIENTES COM DOENÇA HEPÁTICA TERMINAL
    Gabriel Duarte do Nascimento, Gustavo Ribeiro Mesquita, Gilson Augusto Nunes Martins Pombeiro
    Revista Contemporânea.2025; 5(8): e8869.     CrossRef
  • Nationwide analysis of renal outcomes in chronic hepatitis B patients treated with Tenofovir Alafenamide vs. Entecavir
    Hyuk Kim, Jae Young Kim, Hye-Jin Yoo, Log Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the C-reactive protein–triglyceride–glucose index (CTI) and the risk of acute kidney injury in critically ill patients with cirrhosis
    Lu-Huai Feng, Tianbao Liao, Tingting Su, Xuefei Zhou, Yang Lu, Lina Huang, Zhenhua Yang
    BMC Nephrology.2025;[Epub]     CrossRef
  • Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome—Acute Kidney Injury
    Jatin Agrawal, Ashish Kumar, Praveen Sharma, Naresh Bansal, Vikas Singla, Samarth Sharma, Anil Arora
    Journal of Clinical and Experimental Hepatology.2024; 14(1): 101266.     CrossRef
  • Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
    Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
  • VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis
    Shohei Asada, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Takahiro Kubo, Takemi Akahane, Hideto Kawaratani, Norihisa Nishimura, Soichi Takeda, Hiroyuki Masuda, Akihiko Shibamoto, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, Yuki Tsuji, Yukihisa Fujin
    Digestive Diseases and Sciences.2024; 69(3): 851.     CrossRef
  • Evaluation of Kidney Injury Using Arterial Spin Labeling and Blood Oxygen Level‐Dependent MRI: An Experimental Study in Rats With Carbon Tetrachloride‐Induced Liver Cirrhosis
    Jiaming Qin, Shuangshuang Xie, Yongquan Yu, Jiaqi Yang, Yumeng Zhao, Caixin Qiu, Xiaotian Li, Cheng Zhang, Zhandong Hu, Dan Tong, Jinxia Zhu, Bernd Kuehn, Wen Shen
    Journal of Magnetic Resonance Imaging.2024;[Epub]     CrossRef
  • Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
    M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko
    GASTROENTEROLOGY.2024; 58(2): 151.     CrossRef
  • Development and validation of a web-based nomogram for acute kidney injury in acute non-variceal upper gastrointestinal bleeding patients
    Chaolian Wei, Honghua Cao, Lina Huang, Lu-Huai Feng
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?
    Hubert Zywno, Wojciech Figiel, Michal Grat, Slawomir Nazarewski, Zbigniew Galazka, Jolanta Malyszko
    International Journal of Molecular Sciences.2024; 25(22): 12072.     CrossRef
  • Novel biomarkers of acute kidney injury in chronic liver disease: Where do we stand after a decade of research?
    Rohan Vijay Yewale, Balakrishnan Siddartha Ramakrishna
    Hepatology Research.2023; 53(1): 3.     CrossRef
  • Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin C
    Brian L Erstad, David E Nix
    American Journal of Health-System Pharmacy.2023; 80(12): 712.     CrossRef
  • Acute kidney injury in patients with acute-on-chronic liver failure: clinical significance and management
    Jeong-Ju Yoo, Moo Yong Park, Sang Gyune Kim
    Kidney Research and Clinical Practice.2023; 42(3): 286.     CrossRef
  • Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
    Xiao Liu, Shaomin Gong, Yichun Ning, Yang Li, Huili Zhou, Luna He, Lin Lin, Shi Jin, Ziyan Shen, Bowen Zhu, Fang Li, Jie Li, Xiao Tan, Xiaoyan Jiao, Yiqin Shi, Xiaoqiang Ding
    BMC Nephrology.2023;[Epub]     CrossRef
  • Hepatorenal syndrome: Current concepts and future perspectives
    Chan-Young Jung, Jai Won Chang
    Clinical and Molecular Hepatology.2023; 29(4): 891.     CrossRef
  • Diagnostic value of combined detection of urine NGAL, KIM-1, and TFF3 in acute tubular necrosis associated with cirrhosis
    Yan-Qing Gong, Ying Zhao, Yan-Hui Jia, Man Li, Yong Jiang
    World Chinese Journal of Digestology.2023; 31(19): 808.     CrossRef
  • Influence of fluid balance on postoperative outcomes after hepatic resection in patients with left ventricular diastolic dysfunction
    Jungho Shin, Suk-Won Suh
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis
    Pooja Basthi Mohan, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Balaji Musunuri, Ravindra Prabhu Attur, Ganesh Bhat, Shailesh, Shiran Shetty
    Clinica Chimica Acta.2021; 523: 339.     CrossRef
  • 12,407 View
  • 367 Download
  • 24 Web of Science
  • Crossref